Gilead Sciences, Inc. (BCBA:GILD)

Gilead Sciences Revenue

Gilead Sciences had revenue of $7.77B USD in the quarter ending September 30, 2025, with 2.97% growth. This brings the company's revenue in the last twelve months to $29.09B, up 2.78% year-over-year. In the year 2024, Gilead Sciences had annual revenue of $28.75B with 6.04% growth.

• Revenue (ttm): $29.09B
• Revenue Growth: +2.78%
• P/S Ratio: 5.51
• Revenue / Employee: $1.65M
• Employees: 17,600
• Market Cap: 219.72T ARS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	28.75B	1.64B	6.04%
Dec 31, 2023	27.12B	-165.00M	-0.60%
Dec 31, 2022	27.28B	-24.00M	-0.09%
Dec 31, 2021	27.31B	2.62B	10.60%
Dec 31, 2020	24.69B	2.24B	9.98%